|
C12ORF5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.824300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.571570E-04 |
| Normal-vs-Stage2 |
7.814000E-04 |
| Normal-vs-Stage3 |
1.362310E-03 |
| Normal-vs-Stage4 |
4.911200E-01 |
| Stage1-vs-Stage2 |
8.647000E-01 |
| Stage1-vs-Stage3 |
9.367000E-01 |
| Stage1-vs-Stage4 |
4.343900E-03 |
| Stage2-vs-Stage3 |
8.301200E-01 |
| Stage2-vs-Stage4 |
1.281590E-02 |
| Stage3-vs-Stage4 |
2.017700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52362999999989E-05 |
| Normal-vs-AfricanAmerican |
3.810200E-01 |
| Normal-vs-Asian |
4.080800E-01 |
| Caucasian-vs-AfricanAmerican |
5.494300E-02 |
| Caucasian-vs-Asian |
5.92419999999594E-05 |
| AfricanAmerican-vs-Asian |
7.664200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.770100E-04 |
| Normal-vs-Female |
5.839400E-04 |
| Male-vs-Female |
9.466800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.822410E-04 |
| Normal-vs-Age(41-60Yrs) |
6.058800E-03 |
| Normal-vs-Age(61-80Yrs) |
9.223900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.327540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.198580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.671400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.791600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.866000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.446200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.540200E-01 |
| Classical-VS-Follicular |
8.475700E-03 |
| Classical-VS-Other |
6.750400E-01 |
| Classical-VS-Normal |
1.362710E-04 |
| Tall-VS-Follicular |
3.756600E-01 |
| Tall-VS-Other |
6.017800E-01 |
| Tall-VS-Normal |
3.751800E-02 |
| Follicular-VS-Other |
4.235800E-01 |
| Follicular-VS-Normal |
4.465500E-02 |
| Other-VS-Normal |
2.406200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.082300E-03 |
| Normal-vs-N1 |
3.505900E-02 |
| N0-vs-N1 |
7.838800E-01 |
|
|
